Synthetic Biologics, Inc.
BETA-LACTAMASE FORMULATIONS

Last updated:

Abstract:

The present invention provides, in part, formulations comprising a beta-lactamase. Particularly, modified-release powder formulations comprising a beta-lactamase are provided which release a substantial amount of the beta-lactamase in the intestines. Therapeutic uses of the beta-lactamase formulations are also provided.

Status:
Application
Type:

Utility

Filling date:

20 Mar 2018

Issue date:

9 Apr 2020